Penserra Capital Management LLC Rubius Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$9.68 - $17.74 $19,940 - $36,544	-2,060 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.6 - $25.91 $440 - $647	25 Added 1.23%	2,060 $36,000
Q2 2021 Aug 12, 2021	BUY	$22.26 - $28.43 $4,452 - $5,686	200 Added 10.9%	2,035 $49,000
Q1 2021 May 13, 2021	SELL	$8.02 - $32.01 $160 - $640	-20 Reduced 1.08%	1,835 $48,000
Q4 2020 Feb 12, 2021	BUY	$4.23 - $8.73 $4,927 - $10,170	1,165 Added 168.84%	1,855 $14,000
Q3 2020 Nov 13, 2020	BUY	$4.65 - $6.25 $3,208 - $4,312	690 New	690 $3,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.